The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer

Although recent efforts have led to the development of highly effective androgen receptor (AR)-directed therapies for the treatment of advanced prostate cancer, a significant subset of patients will progress with resistant disease including AR-negative tumors that display neuroendocrine features [ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Emmenis, Lucie, Ku, Sheng-Yu, Gayvert, Kaitlyn, Branch, Jonathan R., Brady, Nicholas J., Basu, Subhasree, Russell, Michael, Cyrta, Joanna, Vosoughi, Aram, Sailer, Verena, Alnajar, Hussein, Dardenne, Etienne, Koumis, Elena, Puca, Loredana, Robinson, Brian D., Feldkamp, Michael D., Winkis, Annmarie, Majewski, Nathan, Rupnow, Brent, Gottardis, Marco M., Elemento, Olivier, Rubin, Mark A., Beltran, Himisha, Rickman, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401480/
https://www.ncbi.nlm.nih.gov/pubmed/37546702
http://dx.doi.org/10.1158/2767-9764.CRC-22-0491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401480/
https://www.ncbi.nlm.nih.gov/pubmed/37546702
http://dx.doi.org/10.1158/2767-9764.CRC-22-0491

Ejemplares similares